2seventy bio to Participate in Upcoming Investor Conferences

On February 5, 2024 2seventy bio, Inc. (Nasdaq: TSVT), reported that members of the management team will present at the following upcoming investor conferences (Press release, 2seventy bio, FEB 5, 2024, View Source [SID1234639835]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks 6th Annual Biotechnology Conference, the St. Regis New York, fireside chat on Thursday, February 8th at 1:30 p.m. ET
Citi’s 2024 Virtual Oncology Leadership Summit, Thursday, February 22nd at 3:00 p.m. ET

A live webcast will be available via the Investors and Media section of 2seventy bio’s website at View Source A replay will be archived on 2seventy bio’s site for 30 days following the event.